Skip to main content

Oxford Nanopore Expands Agreement with University of Oxford


Oxford Nanopore Technologies said this week that it has signed a new agreement with the University of Oxford that will further strengthen its ties with its scientific co-founder, Hagan Bayley, a professor at Oxford.

Under the new agreement, which has an undisclosed duration, the company will provide an undisclosed amount of funding to support research in Bayley's group and will partner exclusively with the university to develop "revolutionary products for molecular analysis" based on discoveries made by the group.

Research projects in Bayley's group include the development of methods for direct sequencing of single-stranded DNA. The team receives funding under the National Human Genome Research Institute's "$1,000 Genome" grant program (see other article, this week).

Oxford Nanopore has already collaborated with Bayley's group extensively under a previous agreement.

According to an Oxford Nanopore spokesperson, the new agreement differs from the old one in that it now includes a "broad range of nanopore sensing discoveries" from Bayley's laboratory. The previous agreement, she said, was structured around specific projects.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.